Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018Bashir Al Hussein Al Awamlh, Jonathan E. Shoag, Alec Zhu et al.|JAMA Internal Medicine|2023Cited by 29